Dieter Kube

18.8k total citations · 1 hit paper
76 papers, 3.2k citations indexed

About

Dieter Kube is a scholar working on Pathology and Forensic Medicine, Immunology and Oncology. According to data from OpenAlex, Dieter Kube has authored 76 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Pathology and Forensic Medicine, 34 papers in Immunology and 31 papers in Oncology. Recurrent topics in Dieter Kube's work include Lymphoma Diagnosis and Treatment (34 papers), Immune Cell Function and Interaction (25 papers) and Viral-associated cancers and disorders (16 papers). Dieter Kube is often cited by papers focused on Lymphoma Diagnosis and Treatment (34 papers), Immune Cell Function and Interaction (25 papers) and Viral-associated cancers and disorders (16 papers). Dieter Kube collaborates with scholars based in Germany, United Kingdom and United States. Dieter Kube's co-authors include Hans Tesch, Martina Vockerodt, Grant Gallagher, Joyce Eskdale, Casper Paludan, Christian Münz, Dorothee Schmid, Markus Landthaler, Thomas Tuschl and Volker Diehl and has published in prestigious journals such as Science, Nucleic Acids Research and Nature Communications.

In The Last Decade

Dieter Kube

75 papers receiving 3.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Endogenous MHC Class II Processing of a Viral Nuclear Antigen After Autophagy

2004 674 citations Casper Paludan, Dorothee Schmid et al. Science profile →

Peers

Countries citing papers authored by Dieter Kube

Since Specialization

Citations

This map shows the geographic impact of Dieter Kube's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dieter Kube with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dieter Kube more than expected).

Fields of papers citing papers by Dieter Kube

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dieter Kube. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dieter Kube. The network helps show where Dieter Kube may publish in the future.

Co-authorship network of co-authors of Dieter Kube

This figure shows the co-authorship network connecting the top 25 collaborators of Dieter Kube. A scholar is included among the top collaborators of Dieter Kube based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dieter Kube. Dieter Kube is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Metabolic Changes in Living Human Lymphoma Cells Intervening NAD ⁺ Metabolism as Revealed by NAD (P)H‐Fluorescence Lifetime Imaging and Para‐Hydrogen‐Induced Polarization NMR 2025 ·Cytometry Part A ·(unknown), (unknown), (unknown), (unknown), Gabriele Stevanato, Stefan Glöggler, Raluca Niesner, Dieter Kube	0
2	Real-time cell metabolism assessed repeatedly on the same cells via para-hydrogen induced polarization 2023 ·Chemical Science ·(unknown), Gabriele Stevanato, Frederike von Bonin, Dieter Kube, Stefan Glöggler	6
3	Global, pathway and gene coverage of three Illumina arrays with respect to inflammatory and immune-related pathways 2019 ·European Journal of Human Genetics ·(unknown), Albert Rosenberger, Dieter Kube, Heike Bickeböller	2
4	The NADPH Oxidase Inhibitor Imipramine-Blue in the Treatment of Burkitt Lymphoma 2014 ·Molecular Cancer Therapeutics ·Marcel Klingenberg, Jürgen Becker, Sonja Eberth, Dieter Kube, Jörg Wilting	23
5	Aberrant Lymphocyte Enhancer–Binding Factor 1 Expression Is Characteristic for Sporadic Burkitt’s Lymphoma 2013 ·American Journal Of Pathology ·(unknown), (unknown), Martina Vockerodt, Frederike von Bonin, Wolfram Klapper, Katharina Meyer, Sonja Eberth, Tobias Pukrop, Rainer Spang, Lorenz Trümper, Dieter Kube	29
6	Circulating Levels of TNF Receptor II Are Prognostic for Patients with Peripheral T-cell Non–Hodgkin Lymphoma 2012 ·Clinical Cancer Research ·(unknown), Markus Kreuz, (unknown), Nils Schoof, Frederike von Bonin, Marita Ziepert, Markus Löffler, Wolfram Jung, Michael Pfreundschuh, Lorenz Trümper, Dieter Kube	32
7	Epstein-Barr Virus Infection of Naïve B Cells In Vitro Frequently Selects Clones with Mutated Immunoglobulin Genotypes: Implications for Virus Biology 2012 ·PLoS Pathogens ·Emily Heath, (unknown), Sridhar Chaganti, Debbie Croom-Carter, Claire Shannon‐Lowe, Dieter Kube, Regina Feederle, Henri‐Jacques Delecluse, Alan B. Rickinson, Andrew Bell	56
8	Global gene expression changes of in vitro stimulated human transformed germinal centre B cells as surrogate for oncogenic pathway activation in individual aggressive B cell lymphomas 2012 ·Cell Communication and Signaling ·Alexandra Schrader, Katharina Meyer, Frederike von Bonin, Martina Vockerodt, (unknown), (unknown), (unknown), (unknown), Dido Lenze, Michael Hummel, Arnd Kieser, Michael Engelke, Lorenz Trümper, Dieter Kube	13
9	A Functional Polymorphism in the NAD(P)H Oxidase Subunit CYBA Is Related to Gene Expression, Enzyme Activity, and Outcome in Non–Hodgkin Lymphoma 2010 ·Cancer Research ·Marion Hoffmann, Markus Schirmer, Mladen V. Tzvetkov, Markus Kreuz, Marita Ziepert, Leszek Wojnowski, Dieter Kube, Michael Pfreundschuh, Lorenz Trümper, Markus Loeffler, Jürgen Brockmöller	21
10	STAT3 is essential for Hodgkin lymphoma cell proliferation and is a target of tyrphostin AG17 which confers sensitization for apoptosis 2005 ·Leukemia ·Udo Holtick, Martina Vockerodt, (unknown), Nils Schoof, (unknown), (unknown), Kirsten Lauber, Sebastian Wesselborg, Dennis Löffler, Friedemann Horn, Lorenz Trümper, Dieter Kube	76
11	Endogenous MHC Class II Processing of a Viral Nuclear Antigen After Autophagy breakdown → 2004 ·Science ·Casper Paludan, Dorothee Schmid, Markus Landthaler, Martina Vockerodt, Dieter Kube, Thomas Tuschl, Christian Münz	674
12	The Epstein‐Barr virus oncoprotein latent membrane protein 1 induces expression of the chemokine IP‐10: Importance of mRNA half‐life regulation 2004 ·International Journal of Cancer ·Martina Vockerodt, (unknown), Sigrun Smola‐Hess, (unknown), Richard M. Ransohoff, Hans Tesch, Dieter Kube	40
13	Immunomagnetic enrichment of CD138 positive cells from weakly infiltrated myeloma patients samples enables the determination of the tumor clone specific IgH rearrangement 2001 ·Annals of Hematology ·Andreas Draube, Ronald R. Pfister, Martina Vockerodt, Steven R. Schuster, Dieter Kube, Volker Diehl, Hans Tesch	23
14	The Epstein–Barr Virus Latent Membrane Protein 1 Induces Interleukin-10 in Burkitt's Lymphoma Cells but Not in Hodgkin's Cells Involving the p38/SAPK2 Pathway 2001 ·Virology ·Martina Vockerodt, Birgit Haier, Peter Buttgereit, Hans Tesch, Dieter Kube	76
15	Structural characterisation of the distal 5′ flanking region of the human interleukin-10 gene 2001 ·Genes and Immunity ·Dieter Kube, (unknown), Joyce Eskdale, (unknown), Grant Gallagher	51
16	Loss of IL-6 Receptor Expression in Cervical Carcinoma Cells Inhibits Autocrine IL-6 Stimulation: Abrogation of Constitutive Monocyte Chemoattractant Protein-1 Production 2000 ·The Journal of Immunology ·Sigrun Hess, Hans Smola, (unknown), Dirk Hadaschik, Dieter Kube, (unknown), U. Flucke, Herbert Pfister	42
17	The AT-rich region between −54 to −66 is important for the promoter activity of interleukin-10 in Epstein–Barr virus positive Burkitt’s lymphoma cells 1999 ·Genes and Immunity ·Dieter Kube, (unknown), (unknown), Hans Tesch	13
18	Expression of p56 ^lck in B-Cell Neoplasias 1997 ·Leukemia & lymphoma ·Andreas von Knethen, Harry F. Abts, Dieter Kube, Volker Diehl, Hans Tesch	19
19	Quantitative DNA slot blot analysis: inhibition of DNA binding to membranes by magnesium ions 1997 ·Nucleic Acids Research ·Dieter Kube	44
20	Properties of two epithelial cell lines derived from HPV-associated cervical and vulvar lesions 1993 ·European Journal of Cancer ·(unknown), Dieter Kube, J Janda, Stephan Bergmann, (unknown), Peter Hauff, (unknown), (unknown)	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact